<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03096639</url>
  </required_header>
  <id_info>
    <org_study_id>P-200</org_study_id>
    <nct_id>NCT03096639</nct_id>
  </id_info>
  <brief_title>Percutaneous Temporary Placement of a Phrenic Nerve Stimulator for Diaphragm Pacing</brief_title>
  <acronym>RESCUE2</acronym>
  <official_title>Percutaneous Temporary Placement of a Phrenic Nerve Stimulator for Diaphragm Pacing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lungpacer Medical Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Syntactx</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Lungpacer Medical Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomized clinical trial to investigate the use of the temporary Diaphragm Pacing Therapy
      System (DPTS) to rehabilitate the diaphragm in mechanically ventilated patients who have
      failed at least two weaning attempts. The goal is to strengthen and rehabilitate the
      diaphragm to liberate the patient more quickly from mechanical ventilation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Mechanical ventilation (MV) is a life saving technology but can also cause damage to the
      lungs and diaphragm such as ventricular induced diaphragmatic dysfunction (VIDD). Research
      has shown that after being on mandatory MV and sedated the diaphragm begins to atrophy within
      as short as 18 hours. The Lungpacer Diaphragm Pacing Therapy System (DPTS) is a temporary
      therapy that consists of the Lungpacer IntraVenous Electrode Catheter (LIVE Catheter) and the
      Lungpacer Control Unit system. The LIVE Catheter is a proprietary central venous catheter
      that incorporates pacing electrodes in strategic areas that align with the left and right
      phrenic nerves. The LIVE Catheter can also be used for fluid delivery like any other central
      venous catheter. The randomized clinical trial will investigate the safety, effectiveness and
      performance of the Lungpacer DPTS. By stimulating the diaphragm through daily therapy
      sessions, with the intention of exercising and rehabilitating the diaphragm muscle so the
      patient may be able to be more quickly liberated from MV. The patient population includes
      those who have been mechanically ventilated for greater than or equal to 96 hours (4days),
      have failed two or more spontaneous breathing trials (SBT), and were not hypervolemic during
      the latest spontaneous breathing trial. Patients must have resolution of the initial
      indication for placement on mechanical ventilation before entering the trial.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 14, 2017</start_date>
  <completion_date type="Anticipated">October 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>1:1 randomization of treatment and control group</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>The ultrasound core lab reviewers will be blinded to study allocation groups</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Time to Successful Extubation with No Reintubation within 48 hours</measure>
    <time_frame>Patients will be allowed to stay in the study for up to 30 days if not extubated sooner.</time_frame>
    <description>Removal from mechanical ventilation for greater than or equal to 48 hours during the study duration of 30 days</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to reintubation if applicable</measure>
    <time_frame>from randomization to 30 days</time_frame>
    <description>time placed back on mechanical ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in diaphragmatic thickness on diaphragm ultrasound</measure>
    <time_frame>to successful weaning or on day 30 which ever comes first.</time_frame>
    <description>Evaluate difference in changes in diaphragmatic thickness between study allocation groups from randomization to successful weaning or on day 30 whichever comes first;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in diaphragmatic thickening fraction on diaphragm ultrasound</measure>
    <time_frame>to successful weaning or on day 30 which ever comes first.</time_frame>
    <description>Evaluate difference in changes in diaphragmatic thickening fraction between study allocation groups from randomization to successful weaning or on day 30 whichever comes first;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in MIP</measure>
    <time_frame>Successful weaning, or on day 30, whichever comes first.</time_frame>
    <description>Evaluate difference in changes in MIP between study allocations from randomization successful weaning, or on day 30 post procedure, whichever comes first.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>RSBI</measure>
    <time_frame>Successful weaning, or on day 30 whichever comes first.</time_frame>
    <description>Daily rapid shallow breathing index (RSBI) measurements collected during the SBTs, or on spontaneous breathing mode if unable to perform an SBT.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Ventilator Induced Diaphragm Dysfunction</condition>
  <arm_group>
    <arm_group_label>Diaphragm Pacing Therapy DPTS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Diaphragm Pacing intervention will be conducted 2x a day using the Diaphragmatic Pacing Therapy System (DPTS). The DPTS includes the Lungpacer IntraVenous Electrode Catheter (LIVE Catheter) which is inserted temporarily into the left subclavian vein, the Lungpacer Control Unit (LCU external unit) and an intermediate cable that connects the LCU to the LIVE Catheter.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard of care treatment of weaning failure, no intervention is involved in this control group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Diaphragmatic Pacing Therapy DPTS</intervention_name>
    <description>Subjects will undergo DPTS 2 times a day until successfully extubated with no reintubation within 48 hours.</description>
    <arm_group_label>Diaphragm Pacing Therapy DPTS</arm_group_label>
    <other_name>DPTS</other_name>
    <other_name>LIVE Catheter</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years of age or older

          -  have been mechanically ventilated for &gt; or = to 96 hours (4 days), and

          -  have satisfied the Readiness-to-Wean criteria and

          -  have failed at least two VLTs, one of which is the study specific VLT.

        Exclusion Criteria:

          -  currently on extracorporeal membrane oxygenation (ECMO);

          -  weaning failure due to hypervolemia;

          -  medical history or known anatomy that prevents insertion of the LIVE Catheter into the
             left subclavian vein;

          -  currently being treated with neuromuscular blockade;

          -  clinically overt congestive heart failure that is preventing weaning;

          -  pre-existing neuromuscular diseases that could affect the respiratory muscles;

          -  pre-existing severe chronic pulmonary fibrosis;

          -  pleural effusions occupying greater than one third of the pleural space on either
             side;

          -  BMI &gt; or = 40;

          -  known or suspected phrenic nerve paralysis;

          -  any electrical device (implanted or external) that may be prone to interaction with or
             interference from the Lungpacer DPTS including neurological pacing/stimulator devices,
             cardiac pacemakers and defibrillators;

          -  prior bacteremia reported within the last 48 hours;

          -  current hemodynamic instability, sepsis or septic shock;

          -  terminally ill with 6 months or less life expectancy or not committed to full care;

          -  known or suspected to be pregnant or lactating; and

          -  treatment with an investigational drug or device within 30 days of enrollment.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Linda H Clark, BSN</last_name>
    <role>Study Director</role>
    <affiliation>Vice President of Clinical Affairs, Lungpacer Medical, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Linda H Clark, BSN</last_name>
    <phone>512-633-7077</phone>
    <email>lclark@lungpacer.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alfred Ricer</last_name>
    <email>aricer@lungpacer.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU Angers, Reanimation Medicale</name>
      <address>
        <city>Angers</city>
        <zip>49933</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <email>LaMasson@chu-angers.fr</email>
    </contact>
    <investigator>
      <last_name>Alain Mercat, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pierre Asfar, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Satar Mortaza, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Francois Beloncle, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pierre-Yves Olivier, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Achille Kouatchet, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marc Pierrot, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Louis-Mourier</name>
      <address>
        <city>Colombes</city>
        <zip>92700</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sébastien Besset, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Coralie Gernez</last_name>
      <phone>+33147606767</phone>
      <email>coralie.gernez@aphp.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Didier Dreyfuss, Prof</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sébastien Besset, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Montpellier</name>
      <address>
        <city>Montpellier</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claudine gniadek</last_name>
      <email>c-gniadek@chu-montpellier.fr</email>
    </contact>
    <investigator>
      <last_name>Boris Jung, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Samir Jaber, Prof</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Nice (CHU Nice)</name>
      <address>
        <city>Nice</city>
        <zip>06001</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charles-Hugo Marquette, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Jennifer Griffonnet</last_name>
      <email>griffonnet.j@chu-nice.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Charles-Hugo Marquette, Prof.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fernand Macone, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Europeen Georges-Pompidou</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Luc Diehl, MD</last_name>
      <email>jean-luc.diehl@aphp.fr</email>
    </contact>
    <contact_backup>
      <last_name>Clotilde Bailleul, MD</last_name>
      <email>clotilde.bailleul@aphp.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Jean-Luc Diehl, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Clotilde Bailleul, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Emmanuel Guerot, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pitie Salpetriere Hospital</name>
      <address>
        <city>Paris</city>
        <zip>75651</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Morizot, PhD</last_name>
      <email>Laura.morizot@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Martin Dres, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alexander Demoule, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thomas Similowski, Prof</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Julie Delemazure, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire CHU</name>
      <address>
        <city>Strasbourg</city>
        <zip>67000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ferhat Meziani, Prof. Dr</last_name>
    </contact>
    <contact_backup>
      <last_name>Samir Chenaf</last_name>
      <email>samir.chenaf@chru-strasbourg.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Ferhat Meziani, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Julie Helms, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Raphael Clere-Jehl, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hassene Rahmani, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Uniklinik RWTH Aachen</name>
      <address>
        <city>Aachen</city>
        <zip>52074</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Heart and Diabetes Center Bad Oeynhausen</name>
      <address>
        <city>Bad Oeynhausen</city>
        <zip>32545</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Charite Universitatsmedizin Berlin - Mitte campus</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Holger Muller-Redetzky, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alexander Uhrig, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitatsklinikum Bonn</name>
      <address>
        <city>Bonn</city>
        <zip>53105</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <email>ute.Lohmer@ukbonn.de</email>
    </contact>
    <investigator>
      <last_name>Christian Putensen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thomas Muders, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jens Schewe, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Martin Scholz, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitatsklinik Dresden</name>
      <address>
        <city>Dresden</city>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>PI, Prof. Dr. Med</last_name>
      <email>mgabreu@uniklinijum-dresden.de</email>
    </contact>
    <investigator>
      <last_name>Marcelo G Abreu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andreas Guldner, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christopher Ullig, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Peter Spieth, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Martin Scharffenberg, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitatsmedizin Gottingen, Georg-August-Universitat</name>
      <address>
        <city>Gottingen</city>
        <zip>37075</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <email>akernch@gwdg.de</email>
    </contact>
    <investigator>
      <last_name>Onnen Mörer, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael Quintel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lars-Olav Harnisch, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Asklepios Kliniken Hamburg GmbH - Asklepios Klinikum Harburg</name>
      <address>
        <city>Hamburg</city>
        <zip>21075</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gunther H Wiest, MD</last_name>
      <phone>49 401818862241</phone>
      <email>gu.wiest@asklepios.com</email>
    </contact>
    <contact_backup>
      <last_name>Claudia Heitmann</last_name>
      <phone>49 491818864570</phone>
      <email>cl.heitmann@asklepios.com</email>
    </contact_backup>
    <investigator>
      <last_name>Gunther H Wiest, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Martin Bachmann, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Barbara Schrodter, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Hamburg-Eppendorf (UKE)</name>
      <address>
        <city>Hamburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dominik Jarczak, MD</last_name>
      <email>d.jarczak@uke.de</email>
    </contact>
    <investigator>
      <last_name>Stefan Kluge, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Axel Nierhaus, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Daniel Frings, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dominik Jarczak, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Med Uni-Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69126</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Felix Herth, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Simone Hummler, MD</last_name>
      <email>simone.hummler@med.uni-heidelberg.de</email>
    </contact_backup>
    <investigator>
      <last_name>Felix Herth, Prof. MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Florian Bornitz, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Jena</name>
      <address>
        <city>Jena</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Andreas Kortgen, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Frank Bloos, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Daniel Thomas-Rüddel, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum Nuernberg</name>
      <address>
        <city>Nuernberg</city>
        <zip>90419</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arnim Geise, MD</last_name>
      <email>arnim.geise@klinikum-nuernberg.de</email>
    </contact>
    <investigator>
      <last_name>Arnim Geise, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitatsklinikum Regensburg</name>
      <address>
        <city>Regensburg</city>
        <zip>93053</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maximilian Malfertheiner, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Tanja Emmer</last_name>
      <email>tanja.emmer@ukr.de</email>
    </contact_backup>
    <investigator>
      <last_name>Maximilian Malfertheiner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Matthias Lubnow, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fachkrankenhaus Kloster Grafschaft</name>
      <address>
        <city>Schmallenberg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dominic Dellweg, MD</last_name>
      <email>d.dellweg@fkkg.de</email>
    </contact>
    <investigator>
      <last_name>Dominic Dellweg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wissenschaftliches Institut Bethanien fur Pneumologie e.V.</name>
      <address>
        <city>Solingen</city>
        <zip>42699</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Winfried Randerath, MD</last_name>
      <phone>49 212 63 6001</phone>
      <email>randerath@klinik-bethanien.de</email>
    </contact>
    <investigator>
      <last_name>Winfried Randerath, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lars Hagemeyer, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Simon-Dominik Herkenrath, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Georgios Sofianos, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marcel Treml, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>March 15, 2017</study_first_submitted>
  <study_first_submitted_qc>March 24, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 30, 2017</study_first_posted>
  <last_update_submitted>May 14, 2019</last_update_submitted>
  <last_update_submitted_qc>May 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diaphragm atrophy</keyword>
  <keyword>VIDD</keyword>
  <keyword>Weaning failure</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Only investigators participating in this clinical trial will be able to see final de-identified participant data at the completion of the study and it will be available through the clinical research organization (CRO).</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

